Nanjing Vazyme Biotech Co (SHSE:688105) Institutional Ownership: 2.72% (As of Sep. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688105 Nanjing Vazyme Biotech Co Ltd SHSE:688105
69 GF Score
Price ¥19.50
GF Value ¥21.53
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Nanjing Vazyme Biotech Co Institutional Ownership?

Nanjing Vazyme Biotech Co SHSE:688105 -0.61% 69 Institutional Ownership is 2.72% as of Sep. 12, 2026. GuruFocus rates SHSE:688105 with a GF Score™ of 69/100 and a GF Value™ of ¥21.53 (Fairly Valued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Nanjing Vazyme Biotech Co's institutional ownership is 2.72%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Nanjing Vazyme Biotech Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Nanjing Vazyme Biotech Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Nanjing Vazyme Biotech Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Nanjing Vazyme Biotech Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanjing Vazyme Biotech Co Institutional Ownership Chart

Nanjing Vazyme Biotech Co Historical Data

The historical data trend for Nanjing Vazyme Biotech Co can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 3.23 2.07 2.06 2.06 2.06 2.06 2.06 2.71 2.72 2.72
SHSE:688105
69GF Score
Nanjing Vazyme Biotech Co Ltd SHSE:688105
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanjing Vazyme Biotech Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 2.72% mean?
Nanjing Vazyme Biotech Co (SHSE:688105) has a Institutional Ownership of 2.72% as of Sep. 12, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Nanjing Vazyme Biotech Co and its competitors.
Is Nanjing Vazyme Biotech Co's Institutional Ownership too high?
Nanjing Vazyme Biotech Co's current Institutional Ownership is 2.72%. Overall, Nanjing Vazyme Biotech Co has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nanjing Vazyme Biotech Co's Institutional Ownership compare to VRTX and REGN?
Nanjing Vazyme Biotech Co's Institutional Ownership of 2.72% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Nanjing Vazyme Biotech Co and its competitors. Nanjing Vazyme Biotech Co's current Institutional Ownership is 2.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing Vazyme Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing Vazyme Biotech Co (SHSE:688105) is currently considered Fairly Valued. The stock's GF Value™ is ¥21.53, compared to a current price of ¥19.50 — trading 9.4% below its estimated fair value. The current Institutional Ownership is 2.72%. Nanjing Vazyme Biotech Co's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Nanjing Vazyme Biotech Co (SHSE:688105), the current Institutional Ownership is 2.72% as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanjing Vazyme Biotech Co (SHSE:688105) Overvalued in 2026?

Based on GuruFocus' analysis, Nanjing Vazyme Biotech Co stock appears to be undervalued. The current stock price of ¥19.50 is trading 9.4% below its estimated GF Value™ of ¥21.53. GuruFocus considers Nanjing Vazyme Biotech Co to be Fairly Valued.

Key valuation signals for SHSE:688105:

  • Institutional Ownership: 2.72%
  • GF Value™: ¥21.53 vs. price of ¥19.50 (9.4% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688105 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanjing Vazyme Biotech Co Business Description

Address Kechuang Road, Floor 1-6, East Section, Building C1-2, Hongfeng Science and Technology Park, Jiangsu, Economic and Technological Development Zone, Nanjing, CHN, 210000
Nanjing Vazyme Biotech Co Ltd is a biotechnology company. It is committed to research and development both in technology and products focusing on functional proteins, such as enzymes, antigens, antibodies, and polymer organic materials.
69GF Score

Get the complete analysis for SHSE:688105

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥19.50
Price
¥21.53
GF Value